Inpatient and Outpatient Orderable

Synthetic Cannabinoids (K2 Spice) with Confirmation Build info

Synonyms

  • SYNTHETIC CANNABINOIDS (K2 SPICE) WITH CONFIRMATION
  • K2SPICE
  • LAB11054

Procedure Name

SYNTHETIC CANNABINOIDS (K2 SPICE) WITH CONFIRMATION

Procedure Master Number

LAB11054

Procedure ID

114512

Clinical Info

Detect use of synthetic cannabinoid drugs

Specimen Sources

Bladder Kidney, Left Kidney, Right Ureter, Left Ureter, Right Urine, Catheter Urine, Clean Catch

Specimen Types

Urine

Container

Urine Random

Collection Instructions

Container/Tube: Sterile urine container
Specimen: 10 mL random Urine (5 mL min)
Transport Temperature: Refrigerated
Stability; 3 Days Refrigerated
14 Days Frozen

Specimen Volume

10 mL random Urine (5 mL min)

Transport Instructions

Refrigerated

Specimen Stability

Methodology

Liquid Chromatography/Tandem Mass Spectrometry (LC/MS/MS)
 
This test was developed and its performance characteristics determined by LabCorp. It has not been cleared or approved by the Food and Drug Administration.

Days Performed


TAT 6 -7 Days

Performing Laboratory

Medtox Laboratories, Inc

CPT

80307

PDM

5589042

Only Orderable at Locations:

Orderable Everywhere

Results

Component Name Base Name Common Name External Name
K2, SPICE RESULT K2SPICE K2SPICE K2, Spice

Result Interpretation

Negative
 
Qualitative synthetic cannabinoid analysis includes metabolites of the following: AB-CHMINACA, AB-FUBINACA, AB-PINACA, F-AB-PINACA, ADBICA, 5F-ADBICA, ADB-PINACA, 5F-ADB-PINACA, AKB-48, 5CI-AKB-48, 5F-AKB-48, AM2201, AM694, BB-22, BB-22 hydroxyquinolines, JWH-018, JWH-073, JWH-122, JWH-250, MAB-CHMINACA, MAM-2201, PB-22, PB-22 hydroxyquinolines, 5F-PB-22, 5F-PB-22 hydroxyquinolines, UR-144, XLR-11
 
Screening threshold:  1.0 ng/mL
 
Synthetic Cannabinoid Confirmation analysis includes:
AB-CHMINACA: AB-CHMINACA Butanoic Acid
AB-CHMINACA Hydroxycyclohexyl
AB-FUBINACA: AB-FUBINACA Oxobutanoic Acid
AB-PINACA: AB-PINACA Pentanoic Acid
F-AB-PINACA: AB-PINACA Pentanoic Acid
ADBICA: ADBICA N-(4-hydroxypentyl) and
ADBICA Pentanoic Acid
5F-ADBICA: ADBICA Pentanoic Acid
ADB-PINACA: ADB-PINACA Pentanoic Acid
5F-ADB-PINACA: ADB-PINACA Pentanoic Acid
AKB-48: AKB-48 N-Pentanoic Acid
5Cl-AKB-48: AKB-48 N-Pentanoic Acid
5F-AKB-48: AKB-48 N-Pentanoic Acid
AM2201: JWH-018 N-Pentanoic Acid
AM694: AM694 N-(5-hydroxypentyl)
BB-22: BB-22 3-Carboxyindole
BB-22 hydroxyquinolines: BB-22 3-Carboxyindole
JWH-018: JWH-018 N-Pentanoic Acid
JWH-073: JWH-073 N-Butanoic Acid
JWH-122: MAM-2201 N-Pentanoic Acid
JWH-250: JWH-250 N-(5-Carboxypentyl)
MAB-CHMINACA: MAB-CHMINACA Butanoic Acid
MAM-2201: MAM-2201 N-Pentanoic Acid
PB-22: PB-22 3-Carboxyindole
PB-22 hydroxyquinolines: PB-22 3-Carboxyindole
5F-PB-22: 5F-PB-22 3-Carboxyindole
5F-PB-22-hyroxyquinolines: 5F-PB-22 3-Carboxyindole
UR-144: UR-144 N-Pentanoic Acid
XLR-11: XLR-11 N-(4-Hydroxypentyl) and
UR-144 N-Pentanoic Acid
 
Metabolites may not be unique to the listed parent compounds
as related compounds may have a common metabolic pathway.
 
Screening threshold: 1.0 ng/mL
 
Confirmation threshold: 1.0 ng/mL
 
Analysis performed by Liquid Chromatography with Tandem Mass
Spectrometry (LC/MS/MS).
 
This test was developed and its performance characteristics
determined by LabCorp. It has not been cleared or approved
by the Food and Drug Administration.

Forms

edit